Related Experiment Videos
Review article: managing the dyspeptic patient--an interactive discussion
P Malfertheiner1, V Stanghellini, J P Galmiche
1Department of Gastroenterology, Hepatology, and Infectious Diseases, University of Magdeburg, Leipziger Strasse 44, Haus 39, 39120 Magdeburg, Germany. peter.malfertheiner@medizin.uni-magdeburg.de
Alimentary Pharmacology & Therapeutics
|September 15, 2001
Summary
Challenging dyspepsia cases were discussed by experts. Proton pump inhibitors (PPIs) effectively treat NSAID-induced gastritis and endoscopy-negative reflux disease, while pH monitoring aids reflux diagnosis.
Area of Science:
- Gastroenterology
- Internal Medicine
Background:
- Dyspepsia presents complex clinical challenges requiring expert discussion.
- Interactive case-based learning facilitates diagnosis and treatment strategies for challenging dyspepsia.
Observation:
- Case 1: Recurrent upper GI symptoms in NSAID users without ulcer or H. pylori.
- Case 2: Complex upper GI symptoms including heartburn.
- Case 3: Dyspepsia without alarm symptoms in a young male.
Findings:
- Standard dose proton pump inhibitor (PPI) therapy is optimal for gastritis patients continuing NSAIDs.
- Twenty-four hour pH monitoring effectively links reflux episodes to symptoms.
- Endoscopy-negative reflux disease often responds well to PPI treatment.
Implications:
- Expert dialogue and case reviews enhance clinical decision-making for complex dyspepsia.
- Targeted therapies like PPIs and diagnostic tools like pH monitoring improve patient outcomes.
- A systematic approach is crucial for managing diverse dyspepsia presentations.